ZA201506465B - Pharmaceutical preparation - Google Patents
Pharmaceutical preparationInfo
- Publication number
- ZA201506465B ZA201506465B ZA2015/06465A ZA201506465A ZA201506465B ZA 201506465 B ZA201506465 B ZA 201506465B ZA 2015/06465 A ZA2015/06465 A ZA 2015/06465A ZA 201506465 A ZA201506465 A ZA 201506465A ZA 201506465 B ZA201506465 B ZA 201506465B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA201302883 | 2013-04-22 | ||
PCT/IB2014/060726 WO2014174405A1 (en) | 2013-04-22 | 2014-04-15 | Pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201506465B true ZA201506465B (en) | 2021-06-30 |
Family
ID=51791130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2015/06465A ZA201506465B (en) | 2013-04-22 | 2015-09-03 | Pharmaceutical preparation |
Country Status (2)
Country | Link |
---|---|
WO (1) | WO2014174405A1 (en) |
ZA (1) | ZA201506465B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT307616B (en) * | 1969-05-02 | 1973-05-25 | Biochemie Gmbh | Process for making an effervescent preparation |
GB9007945D0 (en) * | 1990-04-07 | 1990-06-06 | Beecham Group Plc | Pharmaceutical formulation |
EP1541129A1 (en) * | 2003-12-12 | 2005-06-15 | Cimex AG | Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid |
RU2009127496A (en) * | 2006-12-19 | 2011-01-27 | Шеринг-Плоу Лтд. (CH) | BURNING DRUGS OF FLORPHENICOL FOR ADDING TO DRINKING WATER SYSTEMS |
TR201000688A2 (en) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Effervescent formulations containing cefaclor and clavulanic acid as active ingredient. |
WO2011152806A1 (en) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate |
-
2014
- 2014-04-15 WO PCT/IB2014/060726 patent/WO2014174405A1/en active Application Filing
-
2015
- 2015-09-03 ZA ZA2015/06465A patent/ZA201506465B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014174405A1 (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201905426B (en) | Drug combinations | |
PT3030262T (en) | Combined pharmaceutical composition | |
GB201322602D0 (en) | Pharmaceutical compounds | |
GB201306610D0 (en) | Pharmaceutical compounds | |
ZA201602047B (en) | Pharmaceutical compounds | |
SG11201601477VA (en) | Pharmaceutical composition | |
SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
GB201318686D0 (en) | Pharmaceutical preparations | |
ZA201600027B (en) | Pharmaceutical preparation | |
GB201301721D0 (en) | Pharmaceutical Preparations | |
GB201312386D0 (en) | Pharmaceutical compounds | |
HK1220143A1 (en) | Pharmaceutical composition | |
ZA201506465B (en) | Pharmaceutical preparation | |
GB201310496D0 (en) | Pharmaceutical combinations | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201301723D0 (en) | Pharmaceutical combinations | |
GB201317166D0 (en) | Pharmaceutical compounds | |
GB201316780D0 (en) | Pharmaceutical compounds | |
GB201316791D0 (en) | Pharmaceutical Compounds | |
GB201315734D0 (en) | Pharmaceutical compounds | |
GB201315733D0 (en) | Pharmaceutical compounds | |
GB201312464D0 (en) | Pharmaceutical compounds | |
GB201308782D0 (en) | Pharmaceutical compounds | |
GB201308780D0 (en) | Pharmaceutical compounds | |
GB201308781D0 (en) | Pharmaceutical compounds |